HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Yuan Selected Research

gastrin 17 (G 17)

1/2019Clinical significance of serum markers reflecting gastric function and H. pylori infection in colorectal cancer.
10/2018Association between atherosclerosis and gastric biomarkers concerning Helicobacter pylori infection in a Chinese healthy population.
1/2017A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.
6/2015Helicobacter pylori Infection Status Correlates with Serum Parameter Levels Responding to Multi-organ Functions.
3/2014Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
5/2007Factors affecting the serum gastrin 17 level: an evidence-based analysis of 3906 serum samples among Chinese.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Yuan Research Topics

Disease

259Neoplasms (Cancer)
07/2022 - 02/2004
101Stomach Neoplasms (Stomach Cancer)
06/2022 - 03/2002
67Infections
08/2022 - 03/2002
62Breast Neoplasms (Breast Cancer)
12/2022 - 09/2006
45Inflammation (Inflammations)
08/2022 - 05/2005
43Neoplasm Metastasis (Metastasis)
12/2022 - 06/2006
36Fibrosis (Cirrhosis)
01/2022 - 09/2012
34Carcinogenesis
10/2022 - 05/2003
29Atrophic Gastritis
11/2020 - 03/2002
28Adenocarcinoma
07/2021 - 02/2010
26Cardiomegaly (Heart Hypertrophy)
10/2021 - 08/2012
20Triple Negative Breast Neoplasms
01/2022 - 04/2011
19Lymphatic Metastasis
12/2022 - 05/2003
18Carcinoma (Carcinomatosis)
10/2022 - 07/2002
17Lung Neoplasms (Lung Cancer)
04/2021 - 12/2009
16Hepatocellular Carcinoma (Hepatoma)
06/2022 - 02/2010
16Hypoxia (Hypoxemia)
01/2022 - 10/2011
16Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 11/2008
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2020 - 12/2009
15Hypertrophy
01/2022 - 05/2013
15Body Weight (Weight, Body)
01/2022 - 09/2013
15Stomach Diseases
01/2021 - 05/2003
14Pain (Aches)
05/2021 - 10/2009
13Sepsis (Septicemia)
08/2022 - 08/2008
12Liver Neoplasms (Liver Cancer)
06/2022 - 01/2011
12Gastritis
01/2020 - 12/2002
11COVID-19
01/2022 - 01/2020
11Myocardial Infarction
01/2022 - 03/2012
11Atherosclerosis
11/2021 - 12/2005
11Gallbladder Neoplasms (Gallbladder Cancer)
01/2020 - 01/2013
10Wounds and Injuries (Trauma)
11/2021 - 10/2009
10Adenosquamous Carcinoma
01/2020 - 01/2013
9Disease Progression
01/2022 - 09/2010
9Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 01/2014
9Metaplasia
10/2021 - 03/2002
9Prostatic Neoplasms (Prostate Cancer)
12/2019 - 04/2015
8Hyperalgesia
04/2022 - 02/2012
8Necrosis
06/2021 - 07/2012
8Ganglion Cysts (Ganglion)
01/2021 - 01/2005
8Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 09/2013
7Heart Failure
01/2022 - 05/2013
7Adenoma (Adenomas)
01/2022 - 01/2019
6Ovarian Neoplasms (Ovarian Cancer)
05/2022 - 04/2011
6Adenocarcinoma of Lung
04/2022 - 01/2018
6Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2022 - 01/2015

Drug/Important Bio-Agent (IBA)

120Proteins (Proteins, Gene)FDA Link
10/2022 - 02/2003
88Biomarkers (Surrogate Marker)IBA
05/2022 - 05/2007
41MicroRNAs (MicroRNA)IBA
05/2022 - 06/2010
39Biological ProductsIBA
01/2022 - 08/2011
35Pharmaceutical PreparationsIBA
01/2023 - 11/2008
31Messenger RNA (mRNA)IBA
01/2022 - 07/2005
25Long Noncoding RNAIBA
01/2022 - 09/2015
22CytokinesIBA
08/2022 - 08/2008
22DNA (Deoxyribonucleic Acid)IBA
12/2021 - 08/2002
21RNA (Ribonucleic Acid)IBA
01/2022 - 07/2006
18LipidsIBA
06/2022 - 03/2012
18Pepsinogen CIBA
11/2021 - 01/2003
17Circular RNAIBA
10/2022 - 01/2018
15Immunoglobulin G (IgG)IBA
10/2022 - 10/2006
14Glucose (Dextrose)FDA LinkGeneric
01/2022 - 12/2013
13Hormones (Hormone)IBA
06/2022 - 07/2015
13CateninsIBA
12/2021 - 03/2011
12Therapeutic UsesIBA
08/2022 - 01/2016
12EnzymesIBA
06/2022 - 09/2008
12Cisplatin (Platino)FDA LinkGeneric
01/2022 - 12/2009
11Cadherins (E-Cadherin)IBA
12/2022 - 06/2006
11Pepsinogen A (Pepsinogen)IBA
12/2020 - 09/2006
10Angiotensin IIIBA
01/2021 - 05/2013
10AntigensIBA
01/2021 - 03/2002
9LigandsIBA
01/2022 - 01/2011
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 08/2008
8Fatty Acids (Saturated Fatty Acids)IBA
06/2022 - 01/2014
8Immune Checkpoint InhibitorsIBA
06/2022 - 01/2020
8AntioxidantsIBA
02/2022 - 01/2013
8CholesterolIBA
01/2022 - 12/2005
8ErbB Receptors (EGF Receptor)IBA
01/2022 - 02/2010
8Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 11/2015
8oxidized low density lipoproteinIBA
11/2021 - 12/2005
8Tyrosine Kinase InhibitorsIBA
01/2021 - 02/2010
8CalciumIBA
01/2021 - 10/2009
7VaccinesIBA
06/2022 - 01/2014
7Transcription Factors (Transcription Factor)IBA
05/2022 - 01/2011
7Indicators and Reagents (Reagents)IBA
04/2022 - 05/2004
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 08/2008
7Interleukin-6 (Interleukin 6)IBA
02/2021 - 08/2008
7Durapatite (Hydroxylapatite)IBA
01/2021 - 02/2010
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 04/2015
7Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020 - 01/2011
7ImmunosorbentsIBA
12/2018 - 09/2008
6Remifentanil (Ultiva)FDA Link
04/2022 - 02/2012
6InflammasomesIBA
04/2022 - 11/2019
6Estrogen ReceptorsIBA
01/2022 - 01/2016
6Competitive Endogenous RNAIBA
01/2022 - 01/2019
6Docetaxel (Taxotere)FDA Link
01/2022 - 09/2012

Therapy/Procedure

90Therapeutics
01/2023 - 11/2008
40Drug Therapy (Chemotherapy)
07/2022 - 12/2009
14Immunotherapy
01/2022 - 01/2016
13Radiotherapy
01/2022 - 09/2012
10Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2021 - 10/2009
6Punctures
08/2022 - 08/2008